FDA approves groundbreaking new drug for pancreatic cancer

  • Now Playing

    FDA approves groundbreaking new drug for pancreatic cancer

    02:10

  • UP NEXT

    Health Officials Report 2 Measles-Related Deaths in Pennsylvania

    00:32

  • Two deaths reported in Pennsylvania measles outbreak

    02:20

  • FDA Approves New Blood Test to Identify Signs of Alzheimer’s

    00:28

  • What is postpartum psychosis? The mental health condition is at the center of the Lindsay Clancy trial

    03:52

  • Rabbi Shares Tips for Navigating Unexpected Challenges

    04:12

  • What’s Behind the Booming Business of Men’s Grooming?

    04:56

  • CDC investigates cases of salmonella and E.coli linked to alfalfa sprouts

    03:00

  • Formula x Meredith Founder Shares Moves Focusing on Longevity

    03:06

  • Hoda Kotb and Leadership Coach Neal Schore on Being a Leader

    05:49

  • What is Cortisol and Why is It Important?

    05:32

  • Viral Sleep Methods: Which Ones Actually Work?

    06:18

  • FDA upgrades frozen berry recall to highest risk level

    03:24

  • FDA Recalls Clear Eyes Eye Drop Bottles Over Contamination Risk

    00:25

  • Gut Check: Tips to Ensure Stomach Issues Don’t Upset Your Trip

    05:38

  • Moderna, Merck See Promise in Experimental Skin Cancer Vaccine

    00:35

  • Potential new skin cancer vaccine

    01:50

  • Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma

    02:32

  • Favorite Gadgets and Gear to Boost Your Personal Wellness

    03:51

  • How to Keep Your Skin Healthy During the End of Summer

    04:28

NBC News NOW

The Food and Drug Administration approved a groundbreaking new oral drug for pancreatic patients suffering from the most aggressive form of the disease. Daraxonrasib, which targets a mutation in a gene called KRAS, doubled the survival time in patients who participated in the trial.

Source link